The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients (Q81381426)
Jump to navigation
Jump to search
scientific article published on 01 December 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients |
scientific article published on 01 December 2005 |
Statements
The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients (English)
Ohyashiki K
Aota Y
Akahane D
Gotoh A
Miyazawa K
Kimura Y